ISDA

Deposition Date 2008-01-04

Release Date 2008-04-08

Last Version Date 2024-02-21

Entry Detail

PDB ID:

3BV2

Keywords:

TRANSFERASE

Title:

Morpholino pyrrolotriazine P38 Alpha map kinase inhibitor compound 30

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.40 Å

R-Value Free:

0.26

R-Value Work:

0.20

R-Value Observed:

0.20

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Mitogen-activated protein kinase 14
Gene (Uniprot):MAPK14
Chain IDs:A
Chain Length:366
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q16539 Pfam ID:PF00069 EC:2.7.11.24

Ligand Molecules

P38

Primary Citation

Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38 alpha MAP kinase inhibitors.

Wrobleski, S.T, Lin, S, Hynes, J, Wu, H, Pitt, S, Shen, D.R, Zhang, R, Gillooly, K.M, Shuster, D.J, McIntyre, K.W, Doweyko, A.M, Kish, K.F, Tredup, J.A, Duke, G.J, Sack, J.S, McKinnon, M, Dodd, J, Barrish, J.C, Schieven, G.L, Leftheris, K.Show

Bioorg.Med.Chem.Lett. 18 2739 2744 (2008)

PMID: 18364256 DOI: 10.1016/j.bmcl.2008.02.067

Abstact

A novel series of compounds based on the pyrrolo[2,1-f][1,2,4]triazine ring system have been identified as potent p38 alpha MAP kinase inhibitors. The synthesis, structure-activity relationships (SAR), and in vivo activity of selected analogs from this class of inhibitors are reported. Additional studies based on X-ray co-crystallography have revealed that one of the potent inhibitors from this series binds to the DFG-out conformation of the p38 alpha enzyme.

Legend

Protein

Chemical

Disease

Primary Citation of related structures